About Us

  • Our company was established as Soluble Therapeutics in 2008, at Birmingham, AL
  • We commercialized the HSC™ Technology to optimize protein formulations
  • Since inception, we have completed over 25 commercial projects and several academic collaborations including with:
    • BioRad
    • MedImmune
    • Merck
    • Pfizer
    • AbbVie
    • Baxter
    • Catalent
    • Bayer
    • Genmab
  • We acquired Dilyx Biotechnologies in late 2014 and added early assessment solubility and stability kits to the product portfolio
  • We became Soluble Biotech in early 2020 and are now part of Predictive Oncology, Inc. family.
  • Our services are now expanded to pre-formulation developments and post formulation studies, in addition to protein formulation development. Check our Capabilities and Services page.

Please contact us on how we can help with your protein solubility issue!